Effect of Nanosecond Pulsed Electric Fields in Combination with Everolimus on Melanoma.
Jie Dai,Shan Wu,Yan Kong,Zhihong Chi,Lu Si,Xinan Sheng,Chuanliang Cui,Jue Zhang,Jing Fang,Jun Guo
DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.e20102
IF: 45.3
2015-01-01
Journal of Clinical Oncology
Abstract:e20102 Background: Nanosecond pulsed electric field (nsPEF) is a bioelectrical technology generated high voltage electric field in nanosecond duration to destroy tumor cells with non-thermal effect. It is a potential technique for cancer therapy. PI3K/mTOR/AKT pathway is activated in most melanomas, but single agent activity of mTOR inhibitors is limited in advanced melanomas. The aim of the study is to evaluate the anti-growth efficacy of nsPEF in combination with everolimus in melanoma. Methods: Human A375 melanoma cells were exposed to everolimus for 48 hours, followed by 25 pulses of nsPEF with 100 ns duration at the electric field strength of 15 and 20 kV/cm. Cell viability was measured by CellTilter-Glo luminescent cell viability assay 24 hours later. Cell apoptosis and cell cycle were analyzed by flow cytometry. BALB/c mice were inoculated subcutaneously with A375 cells, and randomly divided into four groups: group I as control, group II treated with nsPEF in a single treatment (30 kV/cm, 100 ns, 100 pulses), group III given everolimus (4 mg/kg) by oral gavage daily for 2 weeks, and group IV treated with nsPEF plus everolimus. Results: With the combination of nsPEF, cell growth was decreased gradually according to the nsPEF intensity. nsPEF could induce melanoma cell apoptosis, and the ratio of apoptotic cells was correlated with nsPEF intensity. Cell cycle analysis showed that both everolimus and nsPEF alone could induce G2/M phase arrest, and combination of everolimus with nsPEF could further increase the percentages of G2/M-arrested cells. In vivo experiments showed that the skin lesions caused by nsPEF all healed in one week, and no adverse effect were observed. When compared to control group, the everolimus group, the nsPEF group and the combination group suppressed tumor growth to 32%, 44% and 10%, respectively. Conclusions: nsPEF and everolimus have synergistic anti-tumor effect on melanoma cells through inducing G2/M phase arrest and apoptosis. Our findings indicate that nsPEF in combination with mTOR inhibitor could be used as a potential treatment for advanced melanoma.